Introduction
Subgingival Gram-negative bacteria are associated with the onset and progression of adult periodontitis, with increased populations of a few opportunistic pathogens, including Porphorymonas gingivalis, being seen during development from a healthy site to a diseased site (1, 2) . P. gingivalis has a reportedly high level adherence to erythrocytes and epithelial cells (3) . Hemagglutinins are bacterial surface proteins that often function as adhesins, and bacteria attach to host cells (4) . Multiple hemagglutinin genes have been cloned from P. gingivalis by functional screening (5-7). Among these, hemagglutinin A (HagA) has four large, contiguous, direct repeats and a repeat unit (8) , which is thought to contain the functional domain of hemagglutinin and to be a useful vaccine against periodontitis (9) .
We previously constructed a gene library of P. gingivalis 381 and probed with sera from patients with severe periodontitis, and successfully cloned a 200-kDa antigenic protein (200-k AP) designated pMD101 (10) . To characterize the gene product of pMD101, lysyl endopeptidase digested peptides were prepared from the purified recombinant (r) 200-k AP, and were separated by reverse-phase liquid chromatography, which confirmed that a short peptide, VTVPENGK, was present in HagA (11) . 
Subcloning of the 200-kDa
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Furthermore, DNA sequences of part of the cloned pMD101 were identical to those in the N-terminal region of the hagA gene (12) . Thus, our cloned gene encoding 200-k AP was identical to hagA gene. These findings suggest that pMD101 encodes HagA and that r200-k AP may be useful in developing immunotherapy modalities for periodontal disease. Unfortunately, the gene clone pMD101 exhibits poor recombinant protein production. Thus, in an effort to develop an immunotherapy modality for periodontal disease, we attempted to subclone the gene in order to produce large amounts of useful antigenic protein for development of an antibody.
Materials and Methods
Bacteria and culture P. gingivalis 381 was grown in a brain-heart infusion-0.25% yeast extract supplemented with hemin (5 µg/ml) and menadion (0.5 µg/ml). Cultures were incubated at 37˚C in an anaerobic chamber containing 80% N 2 , 10% H 2 , and 10% CO 2 . Recombinant Escherichia coli clones were grown in LB (trypton, 1%; yeast extract, 0.5%; NaCl, 0.5%).
Agarose gel electrophoresis
Restriction endonuclease digested DNA fragments and λ phage DNA HindIII digests were electrophoresed on 0.8% agarose gels and stained with 0.1% ethidium bromide. DNA fragments were visualized under UV light.
Subcloning, DNA sequencing and homology search Plasmid DNA pMD101 (10) encoding 200-k AP was partially digested with restriction endonuclease HaeIII, methylated and ligated with EcoRI polylinkers. Plasmid vector pMAL-c2 (New England Biolab, MA, USA), which encodes the maltose binding protein (MBP) gene, was digested with EcoRI. Both digested DNAs were ligated with T4 DNA ligase and transformed into E. coli K-12, HB101 host cells using the calcium method. The constructed chimeric clones were screened with antibodies against r200-k AP and were designated as pMD160.
Dideoxy-chain termination DNA sequencing (13) was performed with fluorescent dye-labeled T7 universal primers (Aloka, Japan) and Sequi Therm™ Long-Read™ cycle sequencing kits for Li-Cor ® Sequencing (Epicentre Technologies, USA).
The homology search of cloned DNA sequences was carried out with the standard nucleotide-nucleotide BLAST (blastn) homology search and the amino acid sequencehomology search BLASTP using the NCBI DNA databases.
Purification of recombinant protein
E. coli K-12 host cells harboring pMD160 were harvested from 10 liters of culture medium by centrifugation at 8,500 × g for 30 min at 4˚C. Harvested cells were suspended in 100 ml of buffer A (10 mM Tris-HCl, pH 7.4), and in an ice bath were sonicated at 70 W using a sonifier equipped with a microtip, followed by centrifugation at 28,000 × g for 30 min at 4°C. The supernatant was dialyzed against buffer A and was applied onto a Q Sepharose column (Q Sepharose Hiload, 26 × 100 mm; Pharmacia LKB Biotechnology AB, Uppsala, Sweden) equilibrated with buffer A. Proteins were eluted with an increasing gradient of NaCl (0-500 mM) in buffer A at a flow rate of 2 ml/min. Each collected fraction was dotted onto a nitrocellulose membrane, which were soaked in TBS buffer (10 mM TrisHCl; 0.15 M NaCl, pH 7.5) containing 5% low fat milk (TBS-milk) and gently shaken for 30 min. The membrane was then incubated with antiserum against P. gingivalis 381 cells (500-fold dilution in TBS-milk) at room temperature for 1 h, followed by peroxidase-conjugated goat anti-rabbit IgG (1,000-fold dilution in TBS-milk) at room temperature for 1 h. Peroxidase activity was detected by incubating the filter with TBS buffer containing 0.08% 3,3'-diaminobenzidine tetrahydrochloride and 0.05% H 2 O 2 .
Western blot analysis
Samples were run on a mini slab SDS-polyacrylamide gel electrophoresis (PAGE) gel (7 × 8 cm; 1.0 mm thick) composed of 7% separation gel and 4.5% tracking gel with size standards (Bio-RAD Lab, Hercules, CA, USA; Prestained SDS-PAGE Standards, Lot No. 91270). Cell extracts was dissolved in loading buffer (60 mM TrisHCl, 1% SDS, 7% glycerol, pH 6.8) and filtered through a 0.22-µm Millipore filter. The r130-kDa HMGD protein was purified by electro-osmotic preparative disc gel electrophoresis (14) .
Proteins separated by SDS-PAGE were stained with Coomassie Brilliant Blue R-250, transferred to a nitrocellulose membrane and probed with antibodies. Western blot analysis was carried out as previously reported (12) .
Preparation of vesicles and hemagglutination assay P. gingivalis vesicles were isolated according to the method of Grenier and Mayrand (15) with some modifications, as previously reported (16) .
The hemagglutinating activity of P. gingivalis cells was assayed using rabbit erythrocytes in round-bottomed microtiter plates (17) . Two nanograms of P. gingivalis vesicles was transferred into microtiter wells and incubated with the indicated amount of antibody for 30 min at 37°C, after which 50 µl of 2% (v/v) rabbit erythrocytes was added, and plates were further incubated for 1 h at 37°C.
Results
Plasmid pMD101 was digested with HaeIII, methylated and ligated with EcoRI polylinkers, and was inserted into the EcoRI site of pMAL-c2. Chimeric DNAs were transformed into E. coli K-12, HB101. Ampicilin-resistant chimeric clones were screened using antibodies against r200-k AP. A clone having a 2.7-kb insert was designated as pMD160. Restriction enzyme analysis results are shown in Fig. 1 . Cell extracts from E. coli HB101 harboring pMD160 were prepared and Western blot analysis was carried out using an antibody against r200-k AP. Western blot analysis results in Fig. 2 show that pMD160 encodes a 125-kDa protein and produce much higher amounts of recombinant protein, when compared with pMD101. Since the pMD160 gene clone produced large amounts of recombinant protein encoding the suspected functional domain of hemagglutinin, we selected and further characterized pMD160. pMAL-c2 encodes a 42-kDa MBP peptide, and thus pMD160 should encode an 80-kDa fusion protein of HagA and MBP. We designated this peptide as HagA-80.
DNA sequencing of DNA insert
The entire DNA sequences and deduced amino acid sequences of the 2.7-kb DNA insert in pMD160 are shown in Fig. 3 . HagA-80 contained 2 domains of the expected hemagglutinin functional motif PVQNLT (7) and the first repeat unit region of the P. gingivalis hemagglutinin family. Fig. 4 summarizes the genetic map of hagA and the subcloned gene encoding HagA-80 in pMD160.
The r125-kDa protein was purified to homogeneity using Q Sepharose ion-exchange column chromatography and electro-osmotic preparative disc gel electrophoresis. As shown in Fig. 5A , the final purified sample was homogeneous on SDS-PAGE. Western blot analysis was then carried out using an antibody against r200-k AP. Figure 5B shows that the antibody recognized a r125-kDa protein in the pMD160 cell extracts and the final purified sample.
Rabbits were immunized with the final purified r125-kDa protein and an IgG, designated Ab-Hag-80, was purified using protein G column chromatography. As shown in Fig. 6 , Ab-Hag-80 recognized the r125-kDa protein and r200-AP, the major 43-and 49-kDa bands in cell extracts of P. gingivalis 381 cells, and the r130-kDa HMGD. However, the antibody did not react with MBP on dot blot assay (data not shown).
Finally, the inhibitory effects of Ab-HagA-80 on hemagglutinating activity of P. gingivalis 381 vesicles were examined. As shown in Fig. 7 , the antibody significantly inhibited the hemagglutinating activity of P. gingivalis vesicles, while a commercial antibody against MBP had no effect on the hemagglutinating activity (data not shown). 
Discussion
The hagA gene was isolated via functional screening for hemagglutinating activity (18) , and the gene has been reported to be 7,887 bp in length, encoding a protein of 2,628 amino acids with a molecular mass of 283.3 kDa. Within its open reading frame, four direct repeats were identified, and the repeat unit is thought to contain the hemagglutinin domain. There is extensive homology between this protein and other abundant P. gingivalis proteins, including the proteases PrtP (19) and PrtH (20) , protease RGP-1 (21), protease PrtR (22), argingipain (23) , and Arg1 (24) , in the genome database.
In our studies of the pathogenesis of P. gingivalis and ways to protect against periodontal disease, we prepared the monoclonal antibody MAb-Pg-vc and a recombinant antibody of the single-chain variable fragment (25) , both of which are capable of inhibiting the hemagglutinating activity of P. gingivalis. To clarify the functional domain expressing hemagglutinating activity, we determined the essential motifs responsible for P. gingivalis hemagglutinin. Initially, we cloned the 9-kb EcoRI fragment encoding the 130-kDa heamglutinating domain (HMGD) (7) . From Western blot analysis of nested deletion clones, competition experiments using synthetic peptides, and binding assay of phage-displayed peptides using MAb-Pg-vc, we identified PVQNLT as the essential motif of the functional domain (7) . HagA also possesses a similar amino acid sequence to PVQNLT, and the 130-kDa HMGD is a member of the HagA family (7) .
In this study, we newly subcloned a gene, pMD160, encoding the 80-kDa HagA functional domain (Fig. 4) , which strongly expressed and produced large amounts of recombinant protein (Fig. 2) . The antibody raised against highly purified r80-kDa protein (Fig. 5 ) recognized r200-k AP and the major 43-and 49-kDa bands in cell extracts; it also reacted with r130-kDa HAGD (7) (Fig. 6 ). These findings suggest that the r80-kDa protein contains the antigenic domains of the hemagglutinin gene family. Because it is important to confirm whether r80-kDa protein is useful as a vaccine to inhibit the hemagglutinating activity of P. gingivalis, we investigated the inhibitory effects of the antibody against the hemagglutinating activity of r80-kDa protein.
The results clearly showed significant inhibition of hemagglutinating activity (Fig. 7) . The r125-kDa protein contains a 42-kDa MBP fragment, and thus we examined the immunoreactivity of the antibody against MBP. Western blot analysis revealed that the antibody against MBP did not react with 200-k AP or cell extracts of P. gingivalis 381 cells. Furthermore, the antibody did not affect hemagglutinating activity (data not shown). Considerable scrutiny is required in order to select useful immunogens that can elicit functional protection against the destruction of periodontal tissue induced by oral microorganisms. Adherence to host cells is required for virulence of mucosal pathogens. Consequently, preventing or interfering with the adherence of a particular bacterial pathogen by specific antibodies against the adhesin should prevent colonization and disease (26) . When the P. gingivalis gene expression library was screened for clones that bind human oral epithelial cells, all positive clones were found to have homology with hagA (27) . It was recently found that HagA, a major virulence-associated surface protein, is a potentially useful immunogen that elicits a protective immune response against subsequent colonization by P. gingivalis (9) . Taken together with the results of this study, these data suggest that the r60-kDa protein may be useful for developing a protective vaccine against periodontal diseases associated with P. gingivalis.
Passive immunization approaches against oral infectious diseases have been developed (28) . The periodontal pockets of patients with periodontitis harboring P. gingivalis in their subgingival plaque were treated with antibodies against P. gingivalis cells. Such treatment significantly reduced the recolonization of P. gingivalis for up to 9 months (29) . When considering passive immunization against periodontal diseases, the pathological focus should be on gingival tissues. Application of a specific antibody that neutralizes bacterial agglutination and hemolytic activity can provide practical and satisfactory treatment. The antibody against r80-kDa protein presented here may also be useful in the development of passive immunization as well as in assessing the treatment of periodontal diseases caused by P. gingivalis infection.
